Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.4171
-7.06 %
$ 12.5 M
Market Cap
-0.27
P/E
PRPH - CASH & EQUIVALENTS
Cash & Equivalents PRPH - ProPhase Labs, Inc.
1.61 M
LAST VALUE
-56.25%
2 YEAR CAGR
0.70%
5 YEAR CAGR
-0.18%
10 YEAR CAGR